Valuation: Tactile Systems Technology, Inc.

Market Cap 676M 592M 546M 505M 958M 64.55B 974M 6.53B 2.56B 31.7B 2.54B 2.48B 110B P/E 2026 *
26.8x
P/E 2027 * 19.7x
Enterprise Value 676M 592M 546M 505M 958M 64.55B 974M 6.53B 2.56B 31.7B 2.54B 2.48B 110B EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.7x
Free-Float
97.69%
Yield 2026 *
-
Yield 2027 * -
1 day+2.22%
1 week-2.39%
Current month+2.75%
1 month+16.17%
3 months+27.71%
6 months+1.19%
Current year+5.52%
1 week 29.93
Extreme 29.93
32.44
1 month 25.24
Extreme 25.24
32.44
Current year 20.53
Extreme 20.53
37.77
1 year 9.42
Extreme 9.415
37.77
3 years 8.61
Extreme 8.6098
37.77
5 years 6.28
Extreme 6.28
51
10 years 6.28
Extreme 6.28
76.63
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2024
Director of Finance/CFO 51 20/03/2023
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Director/Board Member 62 13/01/2025
Chairman 66 01/09/2015
Director/Board Member 67 20/09/2017
Date Insider Type Main position Quantity % Market Cap.
05-11Sell

Chief Financial Officer

-4,631 0.0204%
05-06Free

Director

6,521 0.0287%
05-06Free

Chairman

6,521 0.0287%
Change 5-day change 1-year change 3-year change Capi.($)
+2.40%-2.39%+202.07%+25.72% 676M
+0.17%-0.24%+30.03%-2.89% 12.48B
-0.03%-1.66%+63.02%+34.88% 5.99B
+1.60%-0.73%+5.67%+12.17% 5.6B
0.00%-3.62% - - 4.22B
+4.52%+3.68%-31.78%+10.98% 3.92B
-0.58%-2.03%-26.81%-27.99% 3.77B
+0.29%+1.16%-4.34%-58.50% 2.01B
0.00%+2.06%+16.88%+257.78% 1.87B
+2.00%+3.76%+60.13%-4.08% 1.53B
Average +1.07%+1.52%+34.98%+27.56% 4.21B
Weighted average by Cap. +0.80%+0.40%+21.40%+14.67%

Financials

2026 *2027 *
Net sales 365M 319M 294M 272M 517M 34.82B 525M 3.52B 1.38B 17.1B 1.37B 1.34B 59.23B 398M 348M 321M 297M 563M 37.95B 573M 3.84B 1.51B 18.63B 1.49B 1.46B 64.55B
Net income 25.33M 22.16M 20.43M 18.91M 35.88M 2.42B 36.48M 245M 95.92M 1.19B 95.09M 93.03M 4.11B 34.55M 30.23M 27.87M 25.79M 48.95M 3.3B 49.77M 334M 131M 1.62B 130M 127M 5.61B
Net Debt - -
Logo Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
Employees
1,086
Date Price Change Volume
09/07/26 $30.61 +2.08% 63,955
08/07/26 $29.98 -4.80% 199,845
07/07/26 $31.49 -1.19% 260,377
06/07/26 $31.87 +1.66% 185,312
02/07/26 $31.35 +2.28% 382,951
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
29.98USD
Average target price
39.50USD
Spread / Average Target
+31.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TCMD Stock